Medpace Holdings revenue and financials

MEDP · NASDAQ · USD

$602.90−2.84%−$17.61

Close · October 6, 2026

In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.

Annual revenue · 2025: $2.53B

$421.58M2016
$436.15M2017
$704.59M2018
$860.97M2019
$925.93M2020
$1.14B2021
$1.46B2022
$1.89B2023
$2.11B2024
$2.53B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +19.97%; 2025 vs 2024
Net income growth: +11.56%; 2025 vs 2024
Net margin: 17.8%; 2024: 19.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	707	707	708	660	603	559	537	533	528	511	498	492
Cost of revenue	203	198	182	186	186	178	168	172	172	171	164	164
Gross profit	505	508	526	474	417	381	369	362	357	340	334	328
Selling, general and administrative	48.1	47.9	44.9	48.1	46.7	57.9	45.4	49.2	41.5	44.1	42.5	41.4
Operating income	147	142	153	142	126	114	125	112	105	104	87.3	84.9
EBIT	147	142	153	142	126	114	125	112	105	104	87.3	84.9
EBITDA	154	148	160	149	133	120	133	120	112	111	94.3	91.8
Interest expense	—	—	—	—	—	—	—	—	—	—	—	0.1
Pre-tax income	152	148	157	143	125	118	134	119	110	113	90.7	83.2
Income tax	30.3	23.7	21.7	31.7	34.3	3.6	16.9	22.4	22.1	10.2	12.4	12.7
Net income	121	124	135	111	90.3	115	117	96.4	88.4	103	78.3	70.6
Net income to common shareholders	121	124	135	111	90.3	115	117	96.4	88.4	103	78.2	70.5
Basic EPS	4.31	4.35	4.78	3.95	3.16	3.77	3.78	3.11	2.85	3.32	2.55	2.30
Diluted EPS	4.25	4.28	4.66	3.86	3.10	3.67	3.67	3.01	2.75	3.20	2.46	2.22
Average shares (basic)	28.2	28.4	28.3	28.1	28.6	30.4	30.9	31.0	31.0	30.8	30.7	30.6
Average shares (diluted)	28.6	29.0	29.0	28.8	29.1	31.2	31.9	32.1	32.1	32.0	31.8	31.8